MOACM
ITOS

Mutual of America Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Mutual of America Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,883
Closed -$93K – 1520
2022
Q3 		$93K Buy
4,883
+1,481
+44% +$34.1K ﹤0.01% 1537
2022
Q2 		$70K Buy
3,402
+505
+17% +$12K ﹤0.01% 1564
2022
Q1 		$93K Buy
+2,897
New +$105K ﹤0.01% 1532

Other funds holding ITOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mutual of America Capital Management's ITOS Position: Q4 2022 in Review

Mutual of America Capital Management sold out of iTeos Therapeutics (ITOS) in Q4 2022, closing a stake of 4,883 shares — an estimated $93K sold.

Mutual of America Capital Management first reported a position in ITOS in Q1 2022 and held it in 3 quarters. The position peaked at $93K in Q3 2022. 146 funds tracked by Wall St. Rank hold ITOS as of Q4 2022.

  • Mutual of America Capital Management reported no remaining iTeos Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 4,883 iTeos Therapeutics shares in Q4 2022, an estimated $93K.
  • Mutual of America Capital Management first reported a position in iTeos Therapeutics in Q1 2022 and held it in 3 quarters.
  • Mutual of America Capital Management's iTeos Therapeutics position peaked at $93K in Q3 2022.
  • 146 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.